Advertisement

Irish Journal of Medical Science

, Volume 173, Issue 2, pp 96–98 | Cite as

Detection of mycobacterial DNA from sputum of patients with cystic fibrosis

  • M Devine
  • JE MooreEmail author
  • J Xu
  • BC Millar
  • K Dunbar
  • T Stanley
  • PG Murphy
  • AOB Redmond
  • JS Elborn
Original paper

Abstract

Background Patients with cystic fibrosis (CF) are at high risk from atypical mycobacterial infections. There have been few attempts to delineate the intensity of mycobacterial infection in CF patients in Ireland.

Aims To examine the incidence of mycobacterial DNA in an archived collection of genomic DNA extracted from the sputa of CF patients within the Northern Ireland population.

Methods One hundred and eighty-two CF patients (66 adults and 116 children) were examined for the presence of mycobacterial DNA in their sputum by a genus specific PCR assay based on 16S rRNA, followed by direct automated sequencing of the PCR amplicons.

Results One of 116 (0.9%) children and 2 of 66 adults were positive. Sequence identity revealedMycobacterium xenopi in the paediatric patient andM. xenopi andM. chelonei in the two adult patients. False-positive results occurred in 11 patients (four adults), mainly due toCorynebacterium spp.

Conclusions There was a low prevalence ofMycobacterium spp in the CF patient population. All PCR positive results should be confirmed by direct automated sequencing and an alternative specific assay employed. Enhanced molecular screening will contribute in understanding their role as opportunistic pathogens in patients with worsening lung function.

Keywords

Cystic Fibrosis Cystic Fibrosis Patient Nontuberculous Mycobacterium Cystic Fibrosis Sputum Belfast City Hospital 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hutchison ML, Govan JR. Pathogenicity of microbes associated with cystic fibrosis.Microbes Infect 1999; 1: 1005–14.PubMedCrossRefGoogle Scholar
  2. 2.
    Cullen AR, Cannon CL, Mark EJ et al. Mycobacterium abscessus infection in cystic fibrosis. Colonisation or infection?Am J Respir Crit Care Med 2000; 161: 641–45.PubMedGoogle Scholar
  3. 3.
    Kulski JK, Khinsoe C, Pryce T et al. Use of a multiplex PCR to detect and identify Mycobacterium avium and M. intracellulare in blood culture fluids of AIDS patients.J Clin Microbiol 1995; 33: 668–74.PubMedGoogle Scholar
  4. 4.
    Millar B, Moore J, Mallon P et al. Molecular diagnosis of infective endocarditis - a new Duke’s criterion.Scand J Infect Dis 2001; 33 (9): 673- 80.PubMedCrossRefGoogle Scholar
  5. 5.
    Goldenberger D, Kunzli A, Vogt P et al. Molecular diagnosis of bacterial endocarditis by broad-range PCR amplification and direct sequencing.J Clin Microbiol 1997; 35: 2733–9.PubMedGoogle Scholar
  6. 6.
    Griffith DE. Emergence of nontuberculous mycobacteria as pathogens in cystic fibrosis.Am J Respir Crit Care Med 2003; 167: 810–2.PubMedCrossRefGoogle Scholar
  7. 7.
    Ebert DL, Olivier KN. Nontuberculous mycobacteria in the setting of cystic fibrosis.Clin Chest Med 2002; 23: 655–63.PubMedCrossRefGoogle Scholar
  8. 8.
    Olivier KN, Weber DJ, Wallace RJ Jr et al. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis.Am J Respir Crit Care Med 2003; 167: 828–34.PubMedCrossRefGoogle Scholar
  9. 9.
    Olivier KN, Weber DJ, Lee JH et al. Nontuberculous mycobacteria. II: nested- cohort study of impact on cystic fibrosis lung disease.Am J Respir Crit Care Med 2003; 167: 835–840.PubMedCrossRefGoogle Scholar
  10. 10.
    Oliver A, Maiz L, Canton R et al. Nontuberculous mycobacteria in patients with cystic fibrosis.Clin Infect Dis 2001; 32: 1298–303.PubMedCrossRefGoogle Scholar
  11. 11.
    Bange FC, Brown BA, Smaczny C et al. Lack of transmission of Mycobacterium abscessus among patients with cystic fibrosis attending a single clinic.Clin Infect Dis 2001; 32: 1648–50.PubMedCrossRefGoogle Scholar
  12. 12.
    Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis.Am J Respir Crit Care Med 2003; 168: 918–51.PubMedCrossRefGoogle Scholar

Copyright information

© Springer London 2004

Authors and Affiliations

  • M Devine
    • 1
  • JE Moore
    • 1
    Email author
  • J Xu
    • 1
  • BC Millar
    • 1
  • K Dunbar
    • 1
  • T Stanley
    • 1
  • PG Murphy
    • 1
  • AOB Redmond
    • 2
  • JS Elborn
    • 3
  1. 1.Northern Ireland Public Health LaboratoryThe Royal Belfast Hospital for Sick ChildrenNorthern Ireland
  2. 2.Belfast City Hospital, Northern Ireland Regional Paediatric Cystic Fibrosis CentreThe Royal Belfast Hospital for Sick ChildrenNorthern Ireland
  3. 3.Department of Bacteriology and Northern Ireland Regional Adult Cystic Fibrosis CentreThe Royal Belfast Hospital for Sick ChildrenNorthern Ireland

Personalised recommendations